Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Ulstein Legesenter AS
AS
Active
Org 966951214
Sjøgata 3, 6065
Ulsteinvik
General medical practice activities
·
NACE 8621
Est. 1993 · 33 years old
14 employees
Monitor
Share
Norway
/
Companies
/
General medical practice activities
/
Ulstein Legesenter AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
20M
15M
10M
5M
0M
2020: 12M
12M
2020
2021: 13M (+8% vs 2020)
13M
+8%
2021
2022: 14M (+8% vs 2021)
14M
+8%
2022
2023: 15M (+7% vs 2022)
15M
+7%
2023
2024: 16M (+7% vs 2023)
16M
+7%
2024
EBITDA
NOK millions
5M
4M
2M
1M
0M
2020: 3M
3M
2020
2021: 3M (0% vs 2020)
3M
0%
2021
2022: 3M (0% vs 2021)
3M
0%
2022
2023: 4M (+33% vs 2022)
4M
+33%
2023
2024: 4M (0% vs 2023)
4M
0%
2024
Income statement
NOK thousands
Item
2024
2023
2022
2021
2020
Revenue
16 201
14 535
13 739
13 369
12 316
Staff expenses
−6 835
−6 293
−6 179
−5 793
−5 261
EBITDA
3 883
3 517
3 298
3 471
2 884
Depreciation & amort.
−168
−126
−139
−482
−619
EBIT
3 714
3 391
3 158
2 989
2 265
Net financials
109
−27
−32
−34
−49
Profit before tax
3 823
3 364
3 126
2 955
2 216
Tax
854
741
689
651
488
Net profit
2 969
2 622
2 437
2 304
1 728
Balance sheet
NOK thousands
Item
2024
2023
2022
2021
2020
Total assets
5 669
5 592
5 639
5 379
4 906
Equity
136
117
195
233
178
Long-term debt
0
227
481
739
993
Short-term debt
5 532
5 247
4 963
4 407
3 734
Total debt
5 532
5 474
5 444
5 146
4 727
Financial ratios
5-year trend
EBITDA margin
24,0 %
This company
15,8 %
Market median
This company
Market median
52% above market
2020
2024
Equity ratio
2,4 %
This company
38,2 %
Market median
This company
Market median
94% below market
2020
2024
Return on equity
>999 %
This company
18,4 %
Market median
This company
Market median
>999% above market
2020
2024
Net profit margin
18,3 %
This company
8,1 %
Market median
This company
Market median
126% above market
2020
2024
Asset turnover
2,86×
This company
1,12×
Market median
This company
Market median
155% above market
2020
2024
Debt / equity
40,56×
This company
0,62×
Market median
This company
Market median
>999% above market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
More on Ulstein Legesenter AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
